These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6837591)

  • 1. The superiority of the metyrapone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome.
    Sindler BH; Griffing GT; Melby JC
    Am J Med; 1983 Apr; 74(4):657-62. PubMed ID: 6837591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
    van Aken MO; de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):145-9. PubMed ID: 9302385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
    Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the overnight and the standard metyrapone test for the differential diagnosis of adrenocorticotrophin-dependent Cushing's syndrome.
    Avgerinos PC; Nieman LK; Oldfield EH; Cutler GB
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):483-91. PubMed ID: 8959090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O; Jørgensen H; Frey H; Norman N
    Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of steroid laboratory tests and adrenal gland imaging with radiocholesterol in the aetiological diagnosis of Cushing's syndrome.
    Barbarino A; de Marinis L; Liberale I; Menini E
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):107-21. PubMed ID: 428112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cushing's syndrome: diagnostic exploration].
    Tabarin A; Roger P
    Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: a comparison.
    Avgerinos PC; Yanovski JA; Oldfield EH; Nieman LK; Cutler GB
    Ann Intern Med; 1994 Sep; 121(5):318-27. PubMed ID: 8042820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndrome.
    Bruno OD; Rossi MA; Contreras LN; Gómez RM; Galparsoro G; Cazado E; Kral M; Leber B; Arias D
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):158-62. PubMed ID: 2990131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The corticotropin-releasing-hormone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    Lancet; 1986 Sep; 2(8506):540-4. PubMed ID: 2875282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone secretion in alcohol-induced pseudo-Cushing's syndrome. Differential diagnosis with Cushing disease.
    Lamberts SW; Klijn JG; de Jong FH; Birkenhäger JC
    JAMA; 1979 Oct; 242(15):1640-3. PubMed ID: 39183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cortisol levels in Cushing's syndrome after low- and high-dose dexamethasone suppression.
    Ashcraft MW; Van Herle AJ; Vener SL; Geffner DL
    Ann Intern Med; 1982 Jul; 97(1):21-6. PubMed ID: 6212010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome.
    Sriussadaporn S; Ploybutr S; Peerapatdit T; Plengvidhya N; Nitiyanant W; Vannasaeng S; Vichayanrat A
    Br J Clin Pract; 1996; 50(1):9-13. PubMed ID: 8729595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cushing's syndrome: a review of diagnostic tests.
    Crapo L
    Metabolism; 1979 Sep; 28(9):955-77. PubMed ID: 225638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.